Dr. Michael E. Franks, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- University of Maryland School of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,246
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: University of Maryland School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
VA license 0101 240966
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medical College of Virginia Hospitals Richmond, VA
- Bon Secours St Marys Hospital Richmond, VA
- Cjw Medical Center Richmond, VA
- Bon Secours St Francis Medical Center Midlothian, VA
- Henrico Doctors' Hospital Richmond, VA
Medical groups
- Virginia Urology Center (90 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,246
- Services billed
- 30,034
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 7,140 | 38 |
| Injection, testosterone cypionate, 1 mg | 3,800 | 11 |
| Injection, degarelix, 1 mg | 2,160 | 15 |
| High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 1,213 | 13 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,116 | 665 |
| Insertion of needle into vein for collection of blood sample | 896 | 593 |
| Urinalysis, manual test | 824 | 619 |
| Psa (prostate specific antigen) measurement, total | 810 | 545 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 702 | 79 |
| Manual urinalysis test with examination using microscope, non-automated | 325 | 253 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Richmond, VA | 561 |
| Finasteride Other prescribers in Richmond, VA | 264 |
| Prednisone Other prescribers in Richmond, VA | 109 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Richmond, VA | 108 |
| Cefdinir Other prescribers in Richmond, VA | 103 |
| Dutasteride Other prescribers in Richmond, VA | 99 |
| Ciprofloxacin Hcl Other prescribers in Richmond, VA | 91 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Richmond, VA | 88 |
| Abiraterone Acetate | 67 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Richmond, VA | 59 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 106 payments worth $4,596 in total to this clinician.
| Angiodynamics, Inc. | $1,915 |
|---|---|
| Abiomed | $454 |
| Astellas Pharma US Inc | $311 |
| Bayer HealthCare Pharmaceuticals Inc. | $293 |
| Pfizer Inc. | $286 |
| Endo USA, Inc. | $238 |
| Sumitomo Pharma America, Inc. | $193 |
| Janssen Biotech, Inc. | $169 |
| Food and Beverage | $3,197 |
|---|---|
| Travel and Lodging | $1,391 |
| Education | $8.60 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Angiodynamics, Inc. Feb 26, 2025 | Travel and Lodging NANOKNIFE · OS · travel to NASHVILLE, TN · in-kind | $766 |
| Angiodynamics, Inc. Jan 17, 2025 | Travel and Lodging NANOKNIFE · OS · travel to NASHVILLE, TN · in-kind | $363 |
| Abiomed Apr 10, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $262 |
| Bayer HealthCare Pharmaceuticals Inc. Apr 17, 2025 | Education Nubeqa · Oncology · in-kind | $8.60 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $12,441 in research payments for these studies, mostly to the institutions running them.
- A Multi Center Randomized Double Blind Placebo Controlled Phase III Study of ARN509 in Men With Non Metastatic M0 Castration Resistant Prostate Cancer
Janssen Research & Development, LLC - A Phase 3 Randomized Placebo controlled Double blind Study of JNJ56021927 in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects With Chemotherapy naive Metastatic…
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.